Drug class | Drug | Proportion observed agreement | PABAK | 95%CI of PABAK |
---|---|---|---|---|
NNRTI | Efavirenz | 0.94 | 0.88 | (0.86 - 0.91) |
Etravirine | 0.99 | 0.97 | (0.96 - 0.99) | |
Nevirapine | 0.99 | 0.98 | (0.97 - 0.99) | |
NRTI | Abacavir | 0.99 | 0.97 | (0.96 - 0.99) |
Didanosine | 0.99 | 0.97 | (0.96 - 0.99) | |
Emtricitabine | 1.00 | 1.00 | (1.00 -1.00) | |
Lamivudine | 1.00 | 1.00 | (1.00 -1.00) | |
Stavudine | 0.99 | 0.98 | (0.97 - 0.99) | |
Tenofovir | 1.00 | 0.99 | (0.99 - 1.00) | |
Zidovudine | 0.98 | 0.97 | (0.95 - 0.98) | |
PI | Atazanavir/r | 1.00 | 0.99 | (0.99 - 1.00) |
Darunavir/r | 1.00 | 1.00 | (1.00 - 1.00) | |
Lopinavir/r | 1.00 | 1.00 | (0.99 - 1.00) | |
Saquinavir/r | 1.00 | 1.00 | (0.99 - 1.00) | |
Tipranavir/r | 1.00 | 1.00 | (0.99 - 1.00) |